Studies on the mechanism of action of dihydroergotamine (DHE) on the vascular bed of cat skeletal muscle.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D002415:Cats; D002744:Chlorpheniramine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004878:Ergotamine / Q000494:pharmacology*; D008297:Male; D009121:Muscle Denervation; D009132:Muscles / Q000098:blood supply*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects*; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D011941:Receptors, Adrenergic; D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D002744:Chlorpheniramine; D001285:Atropine; D010830:Physostigmine; D011433:Propranolol; D004878:Ergotamine; D001241:Aspirin